| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/26/1996 | CA2216139A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 09/26/1996 | CA2215739A1 Lipophilic peptide hormone derivatives |
| 09/26/1996 | CA2215730A1 Human metabotropic glutamate receptor subtype mglur6 |
| 09/26/1996 | CA2215702A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 09/26/1996 | CA2215694A1 Insulin derivatives |
| 09/26/1996 | CA2215693A1 Tumor marker protein for cancer risk assessment |
| 09/26/1996 | CA2215618A1 Protein production and delivery |
| 09/26/1996 | CA2215414A1 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 09/26/1996 | CA2215387A1 Modulators of ob gene and screening methods therefor |
| 09/26/1996 | CA2215162A1 Vectors for gene delivery |
| 09/26/1996 | CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof |
| 09/26/1996 | CA2215104A1 Compounds and methods for the detection of t. cruzi infection |
| 09/26/1996 | CA2211448A1 Rage tumor rejection antigens |
| 09/26/1996 | CA2190633A1 Novel calcitonin derivatives |
| 09/25/1996 | EP0733903A1 Immunoassay for the detection of urinary cortisol and reagents therefor |
| 09/25/1996 | EP0733708A2 Transferrin-binding protein 1 (Tbp1) gene of Actinobacillus pleuropneumoniae, its use in vaccines for pleuropneumonia and as diagnostic reagents |
| 09/25/1996 | EP0733707A2 Gene participating in the mechanism of secretion of esterase |
| 09/25/1996 | EP0733706A2 Apoptosis-regulating proteins |
| 09/25/1996 | EP0733705A1 Hormone receptor compositions and methods |
| 09/25/1996 | EP0733704A2 Controlable expression system |
| 09/25/1996 | EP0733645A1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome |
| 09/25/1996 | EP0733644A1 Glucagon-like insulinotropic complexes, compositions and methods |
| 09/25/1996 | EP0733643A1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 09/25/1996 | EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells |
| 09/25/1996 | EP0733371A1 Agent for the subcutaneous application of protein C |
| 09/25/1996 | EP0733369A1 Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors |
| 09/25/1996 | EP0733214A1 Dense microsphere components derived from mammalian brain tissue and antibodies thereto |
| 09/25/1996 | EP0733209A1 Composition and method for detection of analytes |
| 09/25/1996 | EP0733206A1 Labelling of nucleic acid analogue-peptide chimerae |
| 09/25/1996 | EP0733205A1 Method for removal of binding proteins from ligands |
| 09/25/1996 | EP0733126A1 Immobilized mismatch binding protein for detection or purification of mutations or polymorphisms |
| 09/25/1996 | EP0733122A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein |
| 09/25/1996 | EP0733118A1 Mammal with enhanced liver expression of a transgene |
| 09/25/1996 | EP0733117A1 Chemically regulatable and anti-pathogenic dna sequences and uses thereof |
| 09/25/1996 | EP0733114A1 CONSTRUCTION OF $i(PASTEURELLA HEAMOLYTICA) VACCINES |
| 09/25/1996 | EP0733111A1 IFN-$g(g)RECEPTOR $g(b)-CHAIN AND DERIVATIVES THEREOF |
| 09/25/1996 | EP0733110A1 Tuberous sclerosis 2 gene and uses thereof |
| 09/25/1996 | EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 09/25/1996 | EP0733108A1 Mutants of bone morphogenetic proteins |
| 09/25/1996 | EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
| 09/25/1996 | EP0733106A1 Plant arabinogalactan protein (agp) genes |
| 09/25/1996 | EP0733105A1 Enhanced transgene expression in specific tissues of the gastrointestinal tract |
| 09/25/1996 | EP0733104A1 Purification of vitamin-k dependent proteins by membrane chromatography |
| 09/25/1996 | EP0733072A1 Antibody against carcinoembryonic antigen (cea) |
| 09/25/1996 | EP0733071A1 Antagonists to chaperonin 10 |
| 09/25/1996 | EP0733069A1 Purified primate ctla-8 antigens and related reagents |
| 09/25/1996 | EP0733068A1 METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF $i(NEU) MEDIATED TRANSFORMATION |
| 09/25/1996 | EP0733067A1 N-terminally chemically modified protein compositions and methods |
| 09/25/1996 | EP0733066A1 Pretargeting methods and compounds |
| 09/25/1996 | EP0733065A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
| 09/25/1996 | EP0733064A1 NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, $i(DER P) III, AND USES THEREFOR |
| 09/25/1996 | EP0733063A1 Compositions and kits for fluorescence polarization assay of large molecules |
| 09/25/1996 | EP0733062A1 Protecting nucleic acids and methods of analysis |
| 09/25/1996 | EP0733061A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 09/25/1996 | EP0733059A1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 09/25/1996 | EP0733057A1 Origin of replication complex genes, proteins and methods |
| 09/25/1996 | EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 09/25/1996 | EP0732937A1 Non-toxic mucosal adjuvant |
| 09/25/1996 | EP0732935A1 Lyophilized stem cell factor formulations |
| 09/25/1996 | EP0732934A1 Long-acting injection suspensions and a process for their preparation |
| 09/25/1996 | EP0732933A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 09/25/1996 | EP0732932A1 Use of urinastatin-like compounds to prevent premature delivery |
| 09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 09/25/1996 | EP0587805B1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/25/1996 | EP0511308B1 Chimeric immunoglobulin for cd4 receptors |
| 09/25/1996 | EP0502050B1 A protein purification method |
| 09/25/1996 | EP0458940B1 Method for the quantitative detection of thyrotropine (tsh) or of anti-thyrotropine receptor autoantibodies (anti-tshr) using a recombinant thyrotropin receptor polypeptide and kit for conducting said method |
| 09/25/1996 | EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 09/25/1996 | CN1131970A Glucan elicitor receptor and DNA coding for the same |
| 09/25/1996 | CN1131952A Single-chain forms of glycoprotein hormone quartet |
| 09/25/1996 | CN1131950A Recombinant C140 receptor and its agonists and antagonists |
| 09/25/1996 | CN1131674A Glucagon insulinotropic complexes, compositions and methods |
| 09/25/1996 | CA2172451A1 Process for the immunologic determination of cortisol, especially urinary cortisol, and reagents used |
| 09/25/1996 | CA2172443A1 Transferrin-binding protein 1 (tbp1) gene of actinobacillus pleuropneumoniae, its use to prepare products for the utilization in vaccines for pleuropneumonia and as diagnostic reagents |
| 09/25/1996 | CA2171668A1 Expression system which can be regulated |
| 09/24/1996 | US5559223 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
| 09/24/1996 | US5559213 Polyethylene-protein conjugates |
| 09/24/1996 | US5559212 Frog embryo and egg-derived tumor cell anti-proliferation protein |
| 09/24/1996 | US5559211 Biologically active product produced by streptococcus pyogenes and method of purification |
| 09/24/1996 | US5559209 Regulator regions of G proteins |
| 09/24/1996 | US5559208 Anti-obesity proteins |
| 09/24/1996 | US5559099 Penton base protein and methods of using same |
| 09/24/1996 | US5559097 Use of a pregnancy specific protein as an immunosuppressive |
| 09/24/1996 | US5559095 Delayed treatment method of reducing ischemia-related neuronal damage |
| 09/24/1996 | US5559094 AspB1 insulin analogs |
| 09/24/1996 | US5559093 N-terminally truncated hst-1 is a platelet-increasing factor |
| 09/24/1996 | US5559034 Synergistic antifungal protein and compositions containing same |
| 09/24/1996 | US5559028 Methods of enhancing or antigen presentation to T cells inhibiting |
| 09/24/1996 | US5559026 Isolated dna from drosophila and caenorhabditis; genetic engineering |
| 09/24/1996 | US5559025 Expression of mature proteinase 2A, the partial purification thereof and preparation of substrates having an inhibitory effect |
| 09/24/1996 | US5559023 Tumor suppressor gene |
| 09/24/1996 | US5559021 DNA encoding a novel mammalian transporter homologous to neurotransmitter transporters and uses thereof |
| 09/24/1996 | US5559014 Methods and reagents to detect and characterize Norwalk and related viruses |
| 09/24/1996 | US5559011 Nucleic acids encoding membrane-associated immunogens of mycobacterial and corresponding probes, vectors, and transformed host cells |
| 09/24/1996 | US5559010 Nutrient regulated gene expression systems |
| 09/24/1996 | US5559009 Voltage-gated potassium channel gene, KV1.7, vectors and host cells comprising the same, and recombinant methods of making potassium channel proteins |
| 09/24/1996 | US5559008 Dna sequences, codes, gene expression, vectors |
| 09/24/1996 | US5559007 Secretion of hirudin from host cell, gene expression, major secretion product of lactococcus |
| 09/24/1996 | US5558999 Genetic engineering |
| 09/24/1996 | US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof |